Financial giants have made a conspicuous bullish move on Pfizer. Our analysis of options history for $Pfizer (PFE.US)$ revealed 15 unusual trades.
Delving into the details, we found 66% of traders were bullish, while 33% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $160,280, and 13 were calls, valued at $525,336.
Predicted Price Range
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $20.0 to $50.0 for Pfizer over the last 3 months.
Volume & Open Interest Trends
In today's trading context, the average open interest for options of Pfizer stands at 20000.89, with a total volume reaching 53,584.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Pfizer, situated within the strike price corridor from $20.0 to $50.0, throughout the last 30 days.
Pfizer Option Activity Analysis: Last 30 Days
Largest Options Trades Observed:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
PFE | PUT | SWEEP | BULLISH | 01/17/25 | $35.00 | $98.2K | 33.5K | 151 |
PFE | CALL | SWEEP | BULLISH | 04/05/24 | $27.00 | $65.8K | 21.3K | 10.0K |
PFE | PUT | SWEEP | BULLISH | 01/17/25 | $35.00 | $62.0K | 33.5K | 68 |
PFE | CALL | SWEEP | BEARISH | 03/28/24 | $27.00 | $50.6K | 67.9K | 10.7K |
PFE | CALL | TRADE | BULLISH | 10/18/24 | $30.00 | $50.0K | 586 | 410 |
About Pfizer
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
In light of the recent options history for Pfizer, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Present Market Standing of Pfizer
Currently trading with a volume of 15,877,576, the PFE's price is up by 0.4%, now at $27.7.
RSI readings suggest the stock is currently may be approaching overbought.
Anticipated earnings release is in 35 days.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.